World Bleeding Disorders Registry

Last updated: August 7, 2023
Sponsor: World Federation of Hemophilia
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hemophilia

Blood Clots

Treatment

N/A

Clinical Study ID

NCT03327779
WBDR
  • All Genders

Study Summary

The WBDR is an international observational disease registry of patients with hemophilia. It will provide a platform for a network of hemophilia treatment centres (HTCs) around the world to collect uniform and standardized patient data and guide clinical practice. With informed consent from the patient, the WBDR stores anonymous data about the person's disease, such as hemophilia type and severity, symptoms, and treatment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients of participating Hemophilia Treatment Centres with Hemophilia A or B, or vonWillebrand Disease

Exclusion

Exclusion Criteria:

  • none

Study Design

Total Participants: 20000
Study Start date:
January 26, 2018
Estimated Completion Date:
January 31, 2028

Study Description

The WBDR is a prospective, global registry of patients diagnosed with hemophilia A and B. Following the success of a pilot study, implementation of the full scale WBDR is underway. The goals are to enroll at least 200 HTCs from more than 50 countries, and at least 10,000 people with hemophilia, during the first five years, aiming for representation of patients from around the world and from all levels of access to care. Minimal criteria for participation of HTCs include access to reliable internet, human resources for data entry and commitment to long-term enrolment and follow-up of patients. The WBDR database is being developed through a collaboration between the WFH, Karolinska Institute and Health Solutions.

By combining data from countries around the world, the WBDR will provide a large amount of real world data, on which researchers can address important scientific and clinical issues. The World Bleeding Disorders Registry (WBDR) is intended to fill existing gaps in knowledge by collecting real world data on the patient clinical experience around the globe.

Connect with a study center

  • World Federation of Hemophilia

    Montréal, Quebec H3G 1T7
    Canada

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.